Source: Investing.com ↗

Oppenheimer cuts Corbus Pharmaceuticals stock price target to $40

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$66,741.65

-4.58%

USDC/USDT

$1.00

-0.02%

ETH/USDT

$1,892.52

-4.19%

SOL/USDT

$75.45

-7.85%

USD1/USDT

$0.9986

-0.06%